Search

Your search keyword '"Dixen U"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Dixen U" Remove constraint Author: "Dixen U"
96 results on '"Dixen U"'

Search Results

2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

7. The left atrial appendage closure by surgery-2 randomized trial

12. P3729The left atrial appendage closure by surgery-2 randomized trial

13. Screening for Atrial Fibrillation

15. Screening for Atrial Fibrillation

16. Club 35 Poster session Friday 13 December: 13/12/2013, 08:30-18:00 * Location: Poster area

17. Increased plasma aldosterone during atrial fibrillation declines following cardioversion

19. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

20. Poster Session 1

21. Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy

25. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review.

26. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation.

27. Signal-averaged P wave duration and the dimensions of the atria.

28. Screening for Atrial Fibrillation

29. 17. Atrial Fibrillation: Pathophysiology and Epidemiology.

30. Club 35 Poster session Friday 13 December: 13/12/2013, 08:30-18:00 * Location: Poster area

31. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

32. Automated oxygen administration versus manual control in acute cardiovascular care: a randomised controlled trial.

33. The acute effects of furosemide in acute heart failure assessed by remote dielectric sensing. A protocol.

34. The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.

35. Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies.

36. The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk.

37. Lenient rate control versus strict rate control for atrial fibrillation: a statistical analysis plan for the Danish Atrial Fibrillation (DanAF) randomized clinical trial.

38. Clinical outcomes of a short-term family-focused intervention for patients with atrial fibrillation-A randomised clinical trial.

39. Feasibility of screening for atrial fibrillation in a domiciliary setting: opportunistic one-time screening at preventive home visits in municipalities.

40. Myocardial fibrosis and ventricular ectopy in patients with non-ischemic systolic heart failure: results from the DANISH trial.

41. Experiences from COVID-19-driven use of telephone consultations in a cardiology clinic-The CoviTel study.

42. Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH Trial.

43. Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.

44. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.

45. NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial.

46. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial.

47. Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial.

48. Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.

49. Pheochromocytoma induced cardiomyopathy in a young man: a case report.

50. Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.

Catalog

Books, media, physical & digital resources